Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AMGN compared with VOR: revenue, margins and what each company keeps, and the suppliers and customers both name
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
VOR
Vor Biopharma Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AMGN
Amgen Inc
vs
VOR
Vor Biopharma Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
8 more · AMGN chain
›
Shared
0
No shared counterparties.
Only VOR
3
—
RemeGen
unlisted
supplier
—
The Trustees of Columbia University in the City of New York
unlisted
customer
—
U.S. Department of Health and Human Services, as represented by National Cancer Institute of the National Institutes of Health
unlisted
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
customer
AMGN
Amgen Inc
Change
461.49
▼
−3.55%
· post 459.00
Mkt cap
$258.8B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
VOR
Vor Biopharma Inc.
Change
18.65
▼
−7.29%
· post 18.55
Closed
Nov 5 '26
Mkt cap
$1.2B
Revenue
—
Revenue
—
vs
Compare
Closed
Nov 5 '26
AMGN
Amgen Inc
vs
VOR
Vor Biopharma Inc.
461.49
▼
−3.55%
post 459.00
Price
18.65
▼
−7.29%
post 18.55
$258.8B
Mkt cap
$1.2B
Q3 FY26
$10.4B
Revenue
—
FY25
$36.8B
Revenue
—
Change
Change
AMGN
461.49
▼
−3.55%
vs
VOR
18.65
▼
−7.29%
Closed
Nov 5 '26